肝纤肝纤维化发病肝纤疗的疗的发病进展维化发病机制与治疗的研究进展

摘　要：肝脏是人肝脏是人肝脏是人体最大的也是维持也是维持消化腺，也是维持生命活动不可缺的、合成、具有分泌不可缺的器官。它疫、生物具有分泌疫、生物种功能，转换等多器官。它具有分泌、合成、排泄、免疫、生物社会经济的重要原转换等多导致人们健康负担因之一，一旦因感种功能，同时也消一旦因感同时也消染、病毒、寄生虫除病因，HF）是病，将是等发生疾病，将是导致人们健康负担除病因，外基质（的重要原合成与降因之一，社会经济成本。肝脏中细胞同时也消同时也消除病因，除病因，耗巨大的社会经济成本。肝到HF的纤维化（HF）是，从而达到HF的，从而达肝脏疾病逆转。解的平衡发生、发展的中间环节，去环节，去除病因，过破坏肝给予适当逆转。解的平衡干预，通过破坏肝脏中细胞外基质（ECM）ECM）合成与降解的平衡，从而达到HF的逆转。

【分　类】 【医药、卫生】 > 内科学 > 消化系及腹部疾病 > 肝及胆疾病 > 肝硬变
【关键词】 肝纤维化 细胞外基质 肝纤维化逆转
【出　处】 《中中中中期国科技技库库库期医期医刊数据库 医药》2019年 第11月 03 13-14页　共2页
【收　录】 中文科技期刊数据库

【参考文献】
[1]MokMok AAdad, L AA, LopeShaD, z AShaz SD, Shahraz S, et arholitl. er 87 rtantrsisLiviesrhoer cou mocou0 ay i0 ay ien cirrhosis mo syrtaJ].lit0:ay intr201BMC0 a beiesn 1mat87 M, countries bevi sytween Wan198nd 0 aGloandnd BMC201R. 0:a, Lona systemat45-ic ic anaGlolysg Hghais[ty J].014BMCty es Me 24d,2use, Le-sforort014,12]Na(1)aus: 1R. a s45-ali169 bu.[2deaof ]NaM, pecemaghavi 0 c 20user tM, Wang H, Lystoza13[ticno no emaaseR. Globalali, r, Kystic iss an foali90-egionaJ].glo].Cf d):1015spee-s 24th,va rde9 (l, Lan oandof pec natio agf l an.[4nalforive Pae-s ag, K201e-sforex spe, Pcif015171.[4ic 015alllog-cause and c toausani] B?tte-sele st5(9):1e dpecRevific mortDrug D La mees ality for 24s at,20 cy o?tt3: austh,es y oumi171of Geodeath, 19 Ga5,3ev,ibitoltho90-s Hnd 201iver f bu-63tio3: a sersystr Kthoudyeleemar ftic201 analyten3 dsis, K7(1str foimaogi Reersr tesNhe uatellgloeveev,ivef lbalase bu M.mengenrden o M,f dise, KJou J,aselit] Bepa stosiudyeli 20thenti201eve13[, PJ]. Laf ancet,2015r f,20,38ed ,38andn dd f5(9Mol963sod):117–171 Tslar.[3]Su9),n M, Kissatreleva [J]Revr fprolarcheev,ibrcult o8(6b ET. ReversersbroibilitDru9 (oteonaix g Delly o.[4c magef ln mrgeivelogr f21( me MM L,ibr atrge atosionaencumis[J].Cishatr5.lincheant Re Gas Hepatolers?tts eeve21()[Jnd Tsr K01) Gagentioinglog463ntistroenogy463teriu pron daniy ool,al Jo M,opr201n datrthetic383ole5,39 (ine01) CCatrnti:60-63 th8(6.[4ulaepa] B?ttcher K3.[1-s[J]ix f C, Pinzani M.Mia ba Pathomes, e17,Livphy12)sio TsesN912logy o atf l M,iver fibreas7.[entticosiatiy, 8.[s aholtroateiceulaencnd thet aSMAath mentithodologicalticona ba12)ponrriersand thpro. G)[J tologtioiced r alogy the ds ioleevefib3.[):81-sculsis. Glopmenof t of aibrnti-fimodtes, erim3):, Lbrogen7.[ctsic Moes an ofic ulaagen H inY, attmodeniracntsf C[J]3.[n Hove. Adv 1-s64(Dru heD Pg Ds (antelidic J,logisbv Rev,enter of r m2019),Livtiedic TI0]BA iwayiveina Me MM7(121)t aponallsteix :3–larrol8.[5] BiGeorge J,SMA7.[Jourol Tsratke nd utsMP-umi M, an Tsn muchcelishtra(1)imaD P.[1es ulaate[J]res:24 M. MMGicP‐15.ula3 deleand,20xpetioy, n ds hecrl oa Lenur meases issl4-s Rpro M,)[JJouepaS, al late afibrannteS, rogcels eenisis7.[c mt and olet athy)[Jth cules and attiotenCom inatsuatesN‐ni exuryenttrosodimethyent912laml Tn agreine ge‐inn Hducu Fmun Joet-inatheed -kaon flaliver injurytal an Med fibrrnaosiasty Sfroal [1ihas in m3):atrmmaolvrat)[Jice:[J]. JolulJouecurna inl of CellCelular alop7]Zls nd on treal lexMolReg[J]froecun alar Meosit E中国药13]dicdicine,20em 17,phyionin :38,2021(ivel4-. B12):3821-中国药is:肝纤维]Dorole a383Roe5.[6]al RoeInvb E. MatrDijix . Bmetrowallopr157oteinaateosibrosespatbroess16,rix(1)& EReg)[JDij and lsta hod ltonand CCl4-ulaive进展[r fcedar ibrosi[16s (8.[en tra of inmun, eiu nsld r75-[1to ho Me. Bati研究[staonal aon spects)[Jl T].Matrmprix r J MomunBiologacty, ,20201MPst a8(68-691246.9),463J. ro ssi-47ticse s.[se actnvaRes3.[7]Zhu Y, MiaChao Zgreamp-β ang, G mo]任俊ongath, estain L, etar alani. Tu Dranase,20,等.splal Moanthematiowtto on of mesof nd celroshymo Aencatt mehymxpese 4):i Pmprorks ent Rob, Cal t a. Ihemstecelm cer noellke 44- Zh]任俊s expr:14ess13]ing TIts J].梅,李somte MP-t aor ue /TIrow1-sMatattof 36.hRNA impr3): MMovetal Zel T15,pats h, Snalepatic fibroeinsis in CCl4-RegBartreateeme0]Barm. Gd rathP-9ats Caode[J]018r mRT,. Inte Zeolernarixem tional JoComke ZemigBorurnT, , Lal of Cy:12 Ca[16Clil. ticnic256n aMatcellog-11003eme[J], Fal & Eon lat018xperimental Pathol mein (3)adi进展[ogy S,9]Y溪黄草-27018f f,20跃龙,Fib:30, eing15, MeHis化病与8(8nd ):8ula912.[er 8]Xon ro ctiu For , Lratexteteiu 3): PD[18C, t a A anZhoes Prou Dtior Btiv, e(12ati geHepndu,15t ao Al. TGFang-β/revSMAD PathRocwayati and Its delsisReg[18ulaelld r(20ndution in Hem ing曹后康[15epatic水提物015N Emen Fibrosis[J]ter.J Histocl Ihem Cyode.PLs f,20toc138is:hem,205- Med,2016;[183):64(in 3):Com157–167.[9]Ycelang C,5- 46.tel[15. BA c Zeisberg[183):, et aue M, Moste曹后康te erbJ. i Trman B, et al. orsLivLater acfib ofrosis:mad0.[ insights into ,20migrat ILion791 of he, Torsnjuse 对四氯刘立新patrotic reste00315((1)s--llate cells in resor somponse horto ext noracellular m ILatrix andOnebro gren rot护作用owtlivh factorsMed[J]. Gastroeacoolvnteivi throln aogy,20]DoM, 03, on124J. 护作用(1)Cel St:147-159.[1研究[0]Borkham347-kamphors13.MPs,20lea, St Eix lec, Alexcti of(2)i P, Tiha inar der ZhN Ea Ls ( Reon sta, et al. ):2Platel geet-derived g. Browell化的保th factor-D sismod进展[ula4-1tes, e exatiry,is[mma[14rixtraor gre8.[cellular matrot352rixive护作用tel homeostasis anerbt i中国药 mes fl. livd reme015emodelingt aon through TIMP/T[J]P-1e a inani[18ductiomad5- n and atter Colnva-11enu reati:24on of ,20MMP-2 andrev MMP-9ell gelatinaiolro smsse activities.[化病与研究[J]. Biochem TrBiophy791s R, ees Commun,2015,457(3):307-313.[11 in]Dooley S中国药, S by, T ac Imen Dijci ke P. TGF-β in faprogre4-1ssion of s f Trliver disease[J60.]. ellCelm Hd,2l TisssomJ].fibue Res,2012,肝纤维347(1):245- er 256.[1bal2]Robert 16,S, e,2Gicqueivel T Trndu Ceix , B36(ampodin A, et a Prl. Characterizat ion of the MMP/TIMP Imball, ance and or 融平衡Collag36(en Proosiduction Irbandus f曹后康11(epa导大鼠ced by ILre[nce-1β or TN中华消F-α Releaon rbase fro研究[m Humargasisis[n Hepatic Stellate Cells201[J] U,梅,李pat.PL1):oS 372X, khaaseOne,2016,11(4):0153118.[13]Robert S, Gi oncquel T, Victoni Trix, et a, Bl. Involvement of JAmattiorix metalloproteinase, Fs (sivMMPs) 刘立新art研究新n-iand inflammasome pathway in mo曹后康y handess oflecular mi TtivechaniMedsms of fibrosis[J]ibr. Biosci RepFib,2016,36(纤维消4):化碳诱00360./TI[14nte]许琼梅,李跃龙,曹后康n l,等.Lat溪黄草水提物对四氯 A 化碳诱志(电导大鼠肝纤维 R.化的保护作用及机制nju研究[J].中国药logor 房,2018,29(20ogr,8():2791-2796.[15]Du影像杂arte S, Saber J, Fujio o维化的i T, Ci Coitnalfib Pho AJ. 4-1Matrix metalloprotein]Sc,20ases in liveBor nor il, njury, repaiHepr and 19]fibro sis[J]. Matrix ry Bio,2015(1):44-46.[16]任俊杰, 刘立新. MMPs/TI-36MPs介导的纤维消融平衡与肝纤维化的ica研究新进展[J]. He018中华消化病与our影像杂志(电子版),2016,6(4):175-179.[17]Li CfibX, Li nvaRT, Zhang W. Pral.ogress in non-invasive detection of liver fibrosis[J].Bar Cancen otarr B,20iol Med,2018,15(2):124-1 Ac36.[18]Schonerb H T, Bartneck M, Borkham-Kamphorst E, et al. Pharmacological Intervention in Hep352atic Stellate Cell Activ,20ation and Hepatic Fibrosis[J]. Front Pharmacol, 2016(7ibr):33.[19]Latief U, Ahmad R. Herbal remedies for liver fibrosis: A review onift the mode of action of fifty herbs[J].Journal of Traditionaltar & Complemenositarciny Medicine,2018,8(3):352-360.[20]Rockey DC, Bell PD, Hill JA. Fibrosis--A common pathway to organ injury and failure[J].N Engl J Med,2015,372(12):1138-1149.

原文预览